华星创业 reported revenue of ¥0.26B for the period ended 2026-06-30, -10.3% year on year. Net income was ¥-0.02B, a -7.1% net margin on a 13.6% gross margin. The largest revenue line is 网络优化及服务 at 96% of the total. Free cash flow for the period was ¥-0.01B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.26B | -10.3% |
| Gross profit | ¥0.04B | — |
| Operating income | ¥-0.02B | — |
| Net income | ¥-0.02B | — |
| Gross margin | 13.6% | Net margin -7.1% |
| Revenue Q/Q | +2.4% | — |
| Segment | Revenue | Share |
|---|---|---|
| 网络优化及服务 | ¥0.25B | 95.6% |
| 其他 | ¥0.01B | 4.3% |
| 系统产品 | ¥0.00B | 0.1% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.23B | 86.4% |
| R&D | ¥0.01B | 3.3% |
| SG&A | ¥0.02B | 9.3% |
| Tax & other | ¥0.00B | 0.7% |
| Item | Amount |
|---|---|
| Total assets | ¥0.69B |
| Total liabilities | ¥0.28B |
| Shareholders' equity | ¥0.41B |
| Equity / assets | 59.6% |
| Operating cash flow | ¥-0.01B |
| Capital expenditure | ¥0.00B |
| Free cash flow | ¥-0.01B |
| Cash conversion (OCF / net income) | 155% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
红日药业 ・ ST华谊 ・ 阳普医疗 ・ 宝通科技 ・ 金龙机电 ・ 钢研高纳 ・ 中科电气 ・ 超图软件 ・ 新宙邦 ・ 上海凯宝 ・ 九洲集团 ・ 回天新材
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies